Brain and whole body distribution of N-isopropyl-4-iodoamphetamine (I-123) in humans : Comparison of radiopharmaceuticals marketed by different companies in Japan
-
- ITO Hiroshi
- Department of Nuclear Medicine and Radiology, Division of Brain Sciences, Institute of Development, Aging and Cancer, Tohoku University
-
- SATO Tachio
- Department of Nuclear Medicine and Radiology, Division of Brain Sciences, Institute of Development, Aging and Cancer, Tohoku University
-
- ODAGIRI Hayato
- Tohoku University Hospital
-
- INOUE Kentaro
- Department of Nuclear Medicine and Radiology, Division of Brain Sciences, Institute of Development, Aging and Cancer, Tohoku University
-
- SHIDAHARA Miho
- Department of Nuclear Medicine and Radiology, Division of Brain Sciences, Institute of Development, Aging and Cancer, Tohoku University
-
- SUHARA Tetsuya
- Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences
-
- HATAZAWA Jun
- Division of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine
-
- FUKUDA Hiroshi
- Department of Nuclear Medicine and Radiology, Division of Brain Sciences, Institute of Development, Aging and Cancer, Tohoku University
Search this article
Journal
-
- Ann Nucl Med.
-
Ann Nucl Med. 20 (7), 493-498, 2006-08-01
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1573950400119780608
-
- NII Article ID
- 10018775286
-
- NII Book ID
- AA10708017
-
- ISSN
- 09147187
-
- Text Lang
- en
-
- Data Source
-
- CiNii Articles